4.3 Article

State-dependent and trait-related gray matter changes in nonrefractory depression

Journal

NEUROREPORT
Volume 26, Issue 2, Pages 57-65

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNR.0000000000000301

Keywords

antidepressant; default network; depression; gray matter; MRI; trait

Categories

Funding

  1. National Science Foundation of China [61420106001, 61375111]
  2. National Basic Research Program of China [2011CB707802]

Ask authors/readers for more resources

Behavioral evidence suggests functional remission or recovery in nonrefractory depressive disorder after successful antidepressant therapy, but the effect of treatment on brain structures remains unclear. It is possible that some specific structural changes are trait-related, in addition to some state-dependent anatomical regions that could be normalized by medications. In the current study, 32 treatment-naive nonrefractory depressive disorder patients and 34 matched healthy controls underwent structural MRI scans and a subgroup including 16 patients underwent the second scans after clinical recovery with antidepressant treatment. The statistical analysis of gray matter images showed that the state-dependent regions mainly comprised the key regions within the lateral default, dorsal attention, and frontoparietal networks, whereas the trait-related regions included the medial prefrontal cortex, right anterior insula, thalamus, right parahippocampal gyrus, and right middle occipital gyrus. Moreover, the gray matter changes in the left orbitofrontal cortex, right middle frontal gyrus, left inferior parietal lobule, thalamus, left precentral gyrus, left precuneus, and right middle occipital gyrus were significantly positively correlated with the durations of the current depressive episode. The current findings may not only shed new light on the neuronal effect of antidepressant on depression but also provide potential evidence of the relapse risks for the clinically recovered patients after antidepressant treatment. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available